Big Pharma joins the U.K.'s genomics project with eyes on drug discovery
01 April 2015
A group of the world's leading drugmakers have joined the U.K.'s ambitious initiative to sequence the genomes of 100,000 Britons, mining the data with hopes of finding new pathways to treat cancer and rare diseases.
Hey, European countries--join forces to bring down drug prices, WHO suggests
01 April 2015
You want to reduce high prices for new meds, European countries? Here's a suggestion for you: Work together.
Purple Day To Raise Epilepsy Awareness
31 March 2015
There is new hope for a recently discovered form of epilepsy that strikes only girls. It’s often misdiagnosed and difficult to treat. Thursday March 26th is designated as Purple Day to raise awareness about epilepsy.
100,000 Genomes Project taps Big Pharma dream team for data crunching skills
31 March 2015
The United Kingdom has wasted no time getting industry involved with its 100,000 Genomes Project. With just 3% of the sequencing work done, Genomics England has enlisted the help of a who's who of Big Pharma companies to pore over the data in search of new avenues for drug discovery.
FDA 'Taking a Very Light Touch' on Regulating the Apple Watch
31 March 2015
With Apple Inc. and fellow Silicon Valley companies edging further into health care, the U.S. agency in charge of oversight says it will give the technology industry leeway to develop new products without aggressive regulation.
CAP, AMP Among Groups Jointly Issuing Colorectal Cancer Molecular Testing Draft Recommendations
31 March 2015
NEW YORK (GenomeWeb) – Several oncology and pathology groups have jointly issued draft recommendations for labs regarding analysis of colorectal cancer patients' samples for certain prognostic and predictive molecular markers.
Fleming Europe Ensuring Quality of Russian Pharma Manufacturing
31 March 2015
Russian pharmaceutical market is developing rapidly, it takes 11th place in the rating of pharmaceutical markets' volume in the world and is predicted to go up to the 9th place by 2016. Along with growing potential, important changes in the industry take place due to governmental program “Pharma 2020”.
Finance giants lobby for JOBS-style reforms to EU IPO laws
30 March 2015
A consortium of financial trade groups has begun lobbying the European Commission to implement the sort of changes that triggered the U.S. biotech IPO boom. The European IPO Task Force specifically wants politicians to slash the regulatory and administrative cost of going public by up to 50%, a move that would make it financially feasible for more small companies to float.
Federal Trade Commission cracking down on questionable mobile medical apps
30 March 2015
Although the FDA is taking a hands-off attitude toward regulating new forms of health information technology, the Federal Trade Commission has stepped up enforcement of those app makers that make false or misleading claims.
100,000 Genomes Project taps Big Pharma dream team for data crunching skills
30 March 2015
The United Kingdom has wasted no time getting industry involved with its 100,000 Genomes Project. With just 3% of the sequencing work done, Genomics England has enlisted the help of a who's who of Big Pharma companies to pore over the data in search of new avenues for drug discovery.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024